Both in Pharmaceuticals
Immunome vs PERRIGO
Over the past year IMNM returned +16.1% and PRGO returned −25.3%; their daily moves had a correlation of 0.18.
IMNM +16.1% PRGO −25.3%Growth of $1, one year, split-adjusted
| Metric | IMNM | PRGO |
|---|---|---|
| Price | $18.29 | $15.90 |
| Market cap | $2.16B | $2.21B |
| Today | −2.51% | −0.13% |
| 1 month | −15.0% | +7.7% |
| 6 months | −20.3% | +34.3% |
| Year to date | −14.9% | +14.2% |
| 1 year | +11.6% | −26.4% |
| Revenue growth (YoY) | −100.0% | −3.2% |
| Gross margin | — | 30.7% |
| Net margin | — | 7.3% |
| P/E (TTM) | — | — |
| Price / sales | — | 0.5× |
| Net cash | $520.0M | -$2.90B |
| Dividend yield | — | 7.30% |
| Volatility (60d) | 55.7% | 42.3% |
| Short % of float | 17.1% | 17.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).